Every year, millions of people suffer brain damage as a result of critical illnesses such as cardiac arrest.
QuickCool AB has developed a cooling method that uses the nasal cavity’s heat exchange capacities to reduce damage to the brain.
The market potential for cooling is extensive and underpenetrated. Many countries have not yet begun to use cooling for the indications: cardiac arrest or difficult-to-treat fever.
We estimate the underpenetrated markets globally to have a value of approx. SEK 1 billion annually, whereas the total global market potential amounts to several billion SEK.